Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Lumpy skin disease virus (LSDV) is a double-stranded DNA virus in the genus Capripoxvirus of the family Poxviridae, featuring a ~151 kbp genome with inverted terminal repeats and 156 genes that support transcription, replication, assembly, and host range adaptation.[4] It causes lumpy skin disease in cattle and ruminants, manifesting as skin nodules, fever, and economic losses through reduced milk production and trade restrictions.[1][4][5] LSDV encodes virulence factors like the LV001/156 protein in its ITR regions, which promotes replication, suppresses interferon signaling via IRF3 interaction, and is present in viral particles.[2] Genomic regions such as GPCR, RPO30, P32, and EEV glycoprotein are used for detection, phylogeny, and distinguishing field strains from vaccines, with variations like 12- or 27-nucleotide insertions marking strains from Asia, Africa, and Europe.[1][3][6] Host-specific within capripoxviruses, it includes homologs of IL-10, chemokine receptors, and growth factors for immune modulation.[4] No small-molecule drugs target LSDV directly; control relies on vaccination and biosecurity amid emerging recombinants.[1][2][8]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lumpy skin disease virus (LSDV).